Literature DB >> 6173446

Expression of HLA-DR antigen in skin from patients with psoriasis.

V B Morhenn, E A Abel, G Mahrle.   

Abstract

Using murine monoclonal antibodies against human HLA-DR antigen and against human T cells, we investigated the indirect immunofluorescence staining pattern of involved and uninvolved skin from patients with psoriasis. The staining pattern of involved psoriatic epidermis is different from the pattern seen in uninvolved skin from the same patient and consists of scattered, single HLA-DR positive cells alternating with groups of HLA-DR positive cells. These HLA-DR positive cell clusters can be seen at any level of the epidermis. In some patients, the dermis of involved skin shows prominent accumulations of T cells which are HLA-DR positive and thus represent activated T cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173446     DOI: 10.1111/1523-1747.ep12506332

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.

Authors:  Z Bata-Csorgo; C Hammerberg; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

2.  Effect of interferons (rIFN-alpha 2, rIFN-gamma) on DNA-synthesis and HLA-DR expression in psoriasis.

Authors:  H J Schulze; G Mahrle
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.

Authors:  A K Gupta; O Baadsgaard; C N Ellis; J J Voorhees; K D Cooper
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor.

Authors:  N I Kim; K D Cooper; G J Fisher; O Baadsgaard; J J Voorhees; C Hammerberg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Cyclosporin A induced augmentation of the beta-adrenergic adenylate cyclase response of pig epidermis.

Authors:  N Kato; K M Halprin; J R Taylor; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Immunohistological skin alterations in allogeneic bone marrow transplantation.

Authors:  C Müller; P Ostendorf; P Wernet; K Schüch; H Wahl; H D Waller
Journal:  Klin Wochenschr       Date:  1984-07-16

7.  Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis.

Authors:  B D Edwards; S M Andrew; J B O'Driscoll; R J Chalmers; F W Ballardie; A J Freemont
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

8.  Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermis.

Authors:  W H Boehncke; A Dahlke; T M Zollner; W Sterry
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

9.  Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis.

Authors:  R E Schopf; A Hoffmann; M Jung; B Morsches; K Bork
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

10.  Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

Authors:  A B Gottlieb; B Lifshitz; S M Fu; L Staiano-Coico; C Y Wang; D M Carter
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.